Invalid Symbol

Stock Research for OPXA

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


OPXA Stock Chart & Research Data

The OPXA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OPXA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OPXA Due diligence Resources & Stock Charts

The OPXA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OPXA Detailed Price Forecast - CNN Money CNN View OPXA Detailed Summary - Google Finance
Yahoo View OPXA Detailed Summary - Yahoo! Finance Zacks View OPXA Stock Research & Analysis -

Stock Analysis

TradeIdeas View OPXA Trends & Analysis - Trade-Ideas Barrons View OPXA Major Holders - Barrons
NASDAQ View OPXA Call Transcripts - NASDAQ Seeking View OPXA Breaking News & Analysis - Seeking Alpha
Spotlight View OPXA Annual Report - OTC Report View OPXA OTC Short Report -
TradeKing View OPXA Fundamentals - TradeKing Charts View OPXA SEC Filings - Bar Chart
WSJ View Historical Prices for OPXA - The WSJ Morningstar View Performance/Total Return for OPXA - Morningstar
MarketWatch View the Analyst Estimates for OPXA - MarketWatch CNBC View the Earnings History for OPXA - CNBC
StockMarketWatch View the OPXA Earnings - StockMarketWatch MacroAxis View OPXA Buy or Sell Recommendations - MacroAxis
Bullish View the OPXA Bullish Patterns - American Bulls Short Pains View OPXA Short Pain Metrics -

Social Media Mentions

StockTwits View OPXA Stock Mentions - StockTwits PennyStocks View OPXA Stock Mentions - PennyStockTweets
Twitter View OPXA Stock Mentions - Twitter Invest Hub View OPXA Investment Forum News - Investor Hub
Yahoo View OPXA Stock Mentions - Yahoo! Message Board Seeking Alpha View OPXA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OPXA - Insider Cow View Insider Transactions for OPXA - Insider Cow
CNBC View OPXA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OPXA - OTC Markets
Yahoo View Insider Transactions for OPXA - Yahoo! Finance NASDAQ View Institutional Holdings for OPXA - NASDAQ

Stock Charts

FinViz View OPXA Stock Insight & Charts - StockCharts View OPXA Investment Charts -
BarChart View OPXA Stock Overview & Charts - BarChart Trading View View OPXA User Generated Charts - Trading View

Latest Financial News for OPXA

Opexa Therapeutics, Inc. Urges Shareholders to Vote FOR the Merger with Acer Therapeutics; The Merger will Not Go Forward Unless ALL Proposals are Approved
Posted on Wednesday September 13, 2017

THE WOODLANDS, TX / ACCESSWIRE / September 13, 2017 / Opexa Therapeutics, Inc. (NASDAQ: OPXA) reminds and urges its shareholders to vote for the proposed merger with Acer Therapeutics, Inc. before the ...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Opexa Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
Posted on Monday September 11, 2017

THE WOODLANDS, TX / ACCESSWIRE / September 11, 2017 / Opexa Therapeutics, Inc. (NASDAQ: OPXA) announced today that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) ...

Opexa Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Posted on Monday August 14, 2017

THE WOODLANDS, TX / ACCESSWIRE / August 14, 2017 / Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, today reported ...

Opexa Therapeutics Sets Date for Special Meeting of Shareholders
Posted on Wednesday August 09, 2017

THE WOODLANDS, TX / ACCESSWIRE / August 9, 2017 / Opexa Therapeutics, Inc. (NASDAQ: OPXA) announced today it has set a date for a special meeting of its shareholders to vote on matters related to the proposed ...

Acer Therapeutics Expands Management Team with the Appointment of Three ...
GlobeNewswire (press release) - Feb 5, 2018
NEWTON, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet ...

Acer Therapeutics Announces Reverse Merger With Houston's Opexa
Xconomy - Jul 5, 2017
[Updated 6/6/17, 8:04 am] Houston—Opexa Therapeutics is the target of a reverse merger with Acer Therapeutics, a privately held pharmaceutical company based in the Boston area. In a filing with the US Securities and Exchange Commission Monday, the ...
Opexa Therapeutics Inc. (NASDAQ:OPXA) Inches Closer To Acer Therapeutics Merger - StockNewsUnion
​Cambridge rare disease startup Acer to go public through merger - Boston Business Journal

Acer Therapeutics Inc.
MarketWatch - Sep 22, 2017
Acer Therapeutics Inc. Acer Therapeutics, Inc. is pharmaceutical company, which engages in th acquisition, development, and intends to commercialize therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need.

Premarket analyst action - healthcare
Seeking Alpha - Feb 16, 2018
Acer Therapeutics (NASDAQ:ACER) initiated with Outperform rating with a $47 (178% upside) price target at William Blair. Shares are up 16% premarket on light volume.
William Blair Starts Acer Therapeutics (ACER) at Outperform -
William Blair Begins Coverage on Acer Therapeutics (ACER) - The Ledger Gazette

Enter a stock symbol to view the stock details.